E F Verdu
Overview
Explore the profile of E F Verdu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
2062
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Balart M, Russell L, Narula N, Bajaj G, Chauhan U, Khan K, et al.
J Can Assoc Gastroenterol
. 2021 Oct;
4(5):214-221.
PMID: 34617003
Background: Corticosteroids (CS) have been used extensively to induce remission in Crohn's disease (CD); however, they are associated with severe side effects. We hypothesized that the administration of an exclusive...
2.
Tuck C, De Palma G, Takami K, Brant B, Caminero A, Reed D, et al.
Sci Rep
. 2020 Oct;
10(1):17784.
PMID: 33082369
The lack of reproducibility of animal experimental results between laboratories, particularly in studies investigating the microbiota, has raised concern among the scientific community. Factors such as environment, stress and sex...
3.
Smecuol E, Constante M, Temprano M, Costa A, Moreno M, Pinto-Sanchez M, et al.
Benef Microbes
. 2020 Oct;
11(6):527-534.
PMID: 33032471
NLS super strain ( NLS-SS) was previously shown to alleviate gastrointestinal symptoms in newly diagnosed coeliac disease (CD) patients consuming gluten. A high proportion of patients following a gluten-free diet...
4.
McCarville J, Dong J, Caminero A, Bermudez-Brito M, Jury J, Murray J, et al.
Appl Environ Microbiol
. 2017 Aug;
83(19).
PMID: 28778891
Microbiota-modulating strategies, including probiotic administration, have been tested for the treatment of chronic gastrointestinal diseases despite limited information regarding their mechanisms of action. We previously demonstrated that patients with active...
5.
Galipeau H, Verdu E
Neurogastroenterol Motil
. 2016 Jun;
28(7):957-65.
PMID: 27339216
Intestinal permeability is a key feature of intestinal barrier function. Altered intestinal permeability is described in many chronic diseases and may be a risk factor for disease development and a...
6.
De Palma G, Blennerhassett P, Lu J, Deng Y, Park A, Green W, et al.
Nat Commun
. 2015 Jul;
6:7735.
PMID: 26218677
Early-life stress is a determinant of vulnerability to a variety of disorders that include dysfunction of the brain and gut. Here we exploit a model of early-life stress, maternal separation...
7.
Laval L, Martin R, Natividad J, Chain F, Miquel S, Desclee de Maredsous C, et al.
Gut Microbes
. 2014 Dec;
6(1):1-9.
PMID: 25517879
Impaired gut barrier function has been reported in a wide range of diseases and syndromes and in some functional gastrointestinal disorders. In addition, there is increasing evidence that suggests the...
8.
Hayes C, Natividad J, Jury J, Martin R, Langella P, Verdu E
Benef Microbes
. 2014 Feb;
5(1):79-88.
PMID: 24533977
Probiotics have been proposed as a therapy for inflammatory bowel disease, but variations in strains, formulations, and protocols used in clinical trials have hindered the creation of guidelines for their...
9.
Collins J, Borojevic R, Verdu E, Huizinga J, Ratcliffe E
Neurogastroenterol Motil
. 2013 Dec;
26(1):98-107.
PMID: 24329946
Background: Normal gastrointestinal function depends on an intact and coordinated enteric nervous system (ENS). While the ENS is formed during fetal life, plasticity persists in the postnatal period during which...
10.
Park A, Collins J, Blennerhassett P, Ghia J, Verdu E, Bercik P, et al.
Neurogastroenterol Motil
. 2013 Jun;
25(9):733-e575.
PMID: 23773726
Background: Depression often coexists with the irritable bowel syndrome (IBS) which is characterized by alterations in gut function. There is emerging evidence that the microbial composition (microbiota) of the gut...